USPTO serial 79285418
SIMPROVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 8, 2021
- Examiner
- FAUCETTE, MAX CLIFFORD STE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SIMPROVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
JP
JP
JP
JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Holly M. Ford Lewis
Holly M. Ford Lewis Oliff PLCP.O. Box 320850Alexandria, VA 22320-4850UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for laboratory or research purposes, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemicals for use in industry and science; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical reagents for use in genetic research; nucleic acid-based reagents, other than for medical or veterinary purposes; chemical and biochemical preparations for industrial or scientific purposes, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes, namely, nucleic acids reagents, buffer solution, aqueous and non-aqueous solutions of alcohols, salts, distilled water, purified water, silica in powdered or granulated form, and magnetic particles in fluid form; chemical materials for reaction vessels for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; reagents and solvents for sample preparation for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical, biochemical and biotechnological products for preparation, purification, lysis, modification and manipulation of samples, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, including nucleic acids made from biological and biochemical sample material, for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; pharmaceutical preparations for the analysis of biological samples; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; nucleic acid-based reagents for medical or veterinary use; diagnostic preparations for medical or veterinary purposes, namely, nucleic acids, marking reagents, buffer chemicals, aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols, salts, distilled water, purified water, and magnetic particles in fluid form; diagnostic preparations for medical or veterinary purposes, namely, materials for reaction vessels for purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds; diagnostic preparations for medical or veterinary purposes, namely, chemical, biochemical and biotechnological products, and kits comprising products for medical or veterinary purposes, namely, chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of biological samples or microorganism, and for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, namely, nucleic acids for medical and veterinary medical purposes, for detecting pathogens, genetic information and conditions of the human body | ACTIVE | — |
| 009 | Downloadable computer software used for medical examinations and diagnoses; computer hardware for data processing for scientific research or medical purposes; downloadable computer software for data processing for scientific research or medical purposes; computer programs, recorded, for the analysis of biological samples or microorganisms for scientific, research, or medical purposes; computer programs, downloadable, for the analysis of biological samples or microorganisms for scientific, research, or medical purposes; laboratory experimental machines and apparatus for the analysis of biological samples or microorganisms for scientific research purposes; laboratory apparatus and instruments for the analysis of biological samples or microorganisms for scientific research purposes; laboratory apparatus and instruments, namely, gene amplifiers; laboratory devices for detecting genetic sequences; molecular probes for scientific purposes other than for medical or veterinary purposes | ACTIVE | — |
| 010 | Diagnostic apparatus for medical purposes for the analysis of biological samples; fully automated nucleic acid-based reading and analysis medical instrument for rapid diagnostic of infections and diseases at point-of-care for personalized healthcare; genetic testing apparatus for medical or veterinary diagnostic use; clinical and medical diagnostic instruments, namely, nucleic acid analyzer; biological sample collection devices in the nature of medical devices for obtaining body fluid samples; medical specimen cups; disposable devices for analysis of biological samples for medical purposes; molecular probes for medical and veterinary medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks owned by EIKEN KAGAKU KABUSHIKI KAISHA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named SIMPROVA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 4, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 25, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 25, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 8, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 21, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 12, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 4, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 4, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 4, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 4, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 11, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 11, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 11, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 8, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 8, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 8, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 18, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 29, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 21, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 14, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |